Antibiotic use was associated with increased risk for some cancers
the ONA take:
Recurrent exposure to antibiotics may increase the risk for cancer in specific organ sites, according to a recent report published in the European Journal of Cancer.
A large population-based electronic medical record database was used to conduct nested case-control studies for 15 common malignancies. Persons with inherited cancer syndromes were excluded. Four eligible matched controls were selected for every case. In total, 125,441 cases and 490,510 matched controls were analyzed.
The findings demonstrated use of penicillin was associated with higher risk of some GI cancers, and this association was higher for those who underwent more antibiotic courses.
Penicillin, cephalosporins, or macrolides use was associated with higher risk for lung cancer; penicillin, quinolones, sulphonamides, and tetracyclines were associated with moderately increased risk for prostate cancer; and sulphonamides were modestly associated with risk for breast cancer. However, no association was found with the use of antivirals and antifungals.
Recurrent exposure to antibiotics may increase the risk for cancer in specific organ sites.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Breast Cancer Screening Recommendations Not Completely Reflective of Race, Age
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|